Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Identify the best retirement plan tailored to your needs. Make informed decisions for a secure financial future.
20,379 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Jeff Bezos reveals a bold new venture positioned to accelerate invention cycles and expand global prosperity, challen...
A surge of headlines about aliens and the Catholic Church is reshaping how investors think about religion, charity, a...
Navitas Semiconductor carved out a standout session as investors reassessed growth catalysts in power semiconductors....
Midwest cities are drawing new capital as Sun Belt rents retreat and new supply cools the boom. The belt boom over. m...
Netflix faces a shifting market environment even as its ad-supported push gains momentum. This piece weighs the buy, ...
Palantir stock soared today as investors priced in a mix of solid results, new government and enterprise wins, and a ...
A famed venture capital fund draws a bold parallel between SpaceX’s post-IPO trajectory and Nvidia’s 2023 surge, fram...
A high-quality, short-duration AAA CLO ETF is drawing attention by offering more income than 3-month Treasuries. For ...
June 2026 opens with a handful of beaten-down stocks that could roar back as inflation cools and earnings beat expect...
A timely dividend safety check: covered reveals JEPI and SPYI pay monthly distributions funded by dividends and optio...
The EU’s MiCA deadline looms, challenging crypto platforms to win licenses or lose EU access. Binance’s Greece strate...